NEWS

HOME
COMPANY
Company Profile
Management Team
Corporate Culture
SCIENCE
Structural Biology Platform
AI-Driven Drug Design Platform
In Vitro Drug Screening Model
In Vivo Drug Efficacy Screening Platform
PIPELINE
Overview
Key indications
NEWS
CONTACTS
Contact Information
Online Message

 EN

EN
CN

COMPANY
Company Profile
Management Team
Corporate Culture
01
SCIENCE
Structural Biology Platform
AI-Driven Drug Design Platform
In Vitro Drug Screening Model
In Vivo Drug Efficacy Screening Platform
02
PIPELINE
Overview
Key indications
03
NEWS
CONTACTS
Contact Information
Online Message
05

HOME
COMPANY
Company Profile
Management Team
Corporate Culture
SCIENCE
Structural Biology Platform
AI-Driven Drug Design Platform
In Vitro Drug Screening Model
In Vivo Drug Efficacy Screening Platform
PIPELINE
Overview
Key indications
NEWS
CONTACTS
Contact Information
Online Message

NEWS

Expanded Access Policy of Chengdu Zenitar Biomedical Technology Co., Ltd.

Sep 17, 2026

Learn more Learn more

Follow the latest happenings in ZENITAR

Driven by unmet clinical needs and enabled by structural biology and AI

LinkedIn: linkedin.com/company/zenitarbiomedical
Email：gangli@zenitar.cn

Online Message Online Message

COMPANY
Company Profile
Management Team
Corporate Culture
SCIENCE
Structural Biology Platform
AI-Driven Drug Design Platform
In Vitro Drug Screening Model
In Vivo Drug Efficacy Screening Platform
PIPELINE
Overview
Key indications
NEWS
CONTACTS
Contact Information
Online Message